| Literature DB >> 32183870 |
Soon-Sun Kwon1, Hyang Kim2,3, Sang-Jin Shin2, Seung Yeol Lee4,5.
Abstract
BACKGROUND: In order to optimize the tenogenic differentiation of mesenchymal stem cells (MSCs), researchers should consider various factors. However, this requires testing numerous experimental settings, which is costly and time-consuming. We aimed to assess the differential effects of transforming growth factor beta-3 (TGF-β3) on the tenogenesis of tonsil-derived MSCs (T-MSCs) and bone marrow-derived MSCs (BM-MSCs) using response surface methodology (RSM).Entities:
Keywords: Bone marrow-derived mesenchymal stem cells; Design of experiments; Response surface methodology; Tenocyte; Tonsil-derived mesenchymal stem cells
Mesh:
Year: 2020 PMID: 32183870 PMCID: PMC7079471 DOI: 10.1186/s13018-020-01623-8
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Primers used in this study*
| Gene | Forward Primer (5'->3') | Reverse Primer (5'->3') | |
|---|---|---|---|
| Adipogenic | PPARγ | GAGGCAGCAGAGGTTAACAGA | CACCGAGGCGTAAAGTACCA |
| LPL | CCGCCGACCAAAGAAGAGAT | TAGCCACGGACTCTGCTACT | |
| FABP4 | TGGGCCAGGAATTTGACGAA | CACATGTACCAGGACACCCC | |
| Osteogenic | RUNX2 | CCTACCTGAGCCAGATGACG | ATGCTGGGTGGCCTGAAAT |
| ALP | GAATCTTCCCCAAGGGCCAA | CAGAATGTTCCACGGAGGCT | |
| BGLAP | TCCTTTGGGGTTTGGCCTAC | CCAGCCTCCAGCACTGTTTA | |
| Chondrogenic | SOX9 | AGGAAGTCGGTGAAGAACGG | AAGTCGATAGGGGGCTGTCT |
| COL2 | GCTCCTGCCGTTTCGCTG | ATTATACCTCTGCCCATCCTGC | |
| ACAN | CTTCCGCTGGTCAGATGGAC | CGTTTGTAGGTGGTGGCTGT | |
| Tenogenic | SCX | ACAGATCTGCACCTTCTGCC | GCCACCTCCTAACTGCGAAT |
| TNMD | TCCCTCAGGCTCTGGTATGA | AGGACTGAGAGACCACTGCT | |
| DCN | TGCCAAAGGATCTTCCCCCT | AGGTGTAAATGCTCCAGGACT | |
| COL1A1 | AGTGGTTTGGATGGTGCCAA | GCACCATCATTTCCACGAGC | |
| COL3A1 | TGGAGGATGGTTGCACGAAA | ACAGCCTTGCGTGTTCGATA | |
| TNC | ATGGGCAGACGCACCATTAG | TGTGCATCGACCTTCACAAGA | |
| Internal control | 18S rRNA | GTAACCCGTTGAACCCCATT | CCATCCAATCGGTAGTAGCG |
*NCBI/ Primer-BLAST: Finding primers specific to your PCR template (using Primer3 and BLAST). Available from: https://www.ncbi.nlm.nih.gov/tools/primer-blast/ (Assessed on 15 December 2017)
ANOVA for response surface model
| MSCs | Source | Sum of squares | Mean square | ||
|---|---|---|---|---|---|
| T-MSCs | Days | 17.57867 | 5.859557 | 9.98 | < 0.001 |
| Concentration of TGF-β3 | 88.30324 | 29.43411 | 50.11 | < 0.001 | |
| BM-MSCs | Days | 37.2556 | 12.4185 | 3.68 | 0.013 |
| Concentration of TGF-β3 | 71.4878 | 23.8293 | 7.07 | < 0.001 |
MSCs mesenchymal stem cells, T-MSCs tonsil-derived mesenchymal stem cells, BM-MSCs bone marrow-derived mesenchymal stem cells
Immunophenotypic markers on the cell surface of T-MSCs and T-MSCs
| BM-MSCs | T-MSCs | ||
|---|---|---|---|
| Positive | CD73 | 99.9 ± 0.05 | 99.9 ± 0.03 |
| CD90 | 99.6 ± 0.00 | 97.7 ± 1.57 | |
| CD105 | 99.8 ± 0.10 | 99.9 ± 0.05 | |
| Negative | CD11b | 1.2 ± 1.00 | 0.23 ± 0.03 |
| CD19 | |||
| CD34 | |||
| CD45 | |||
| HLA-DR | |||
T-MSCs tonsil-derived mesenchymal stem cells, BM-MSCs bone marrow-derived mesenchymal stem cells
Fig. 1Tenogenic mRNA expression of T-MBCs (a) and BM-MSCs (b) exposed to TGF-β3. The peak expression of each mRNA differed slightly according to the culture time and TGF-β3 concentration. The collagen I to III ratio of T-MSCs increased regardless of TGF-β3 concentration, whereas the ratio in BM-MSCs decreased. (*p < 0.05, analyzed by one-way analysis of variance, followed by Tukey’s multiple comparison test)
Optimization of each tenocyte lineage-related factor from T-MSCs and BM-MSCs using response surface methodology
| Estimated value from T-MSCs | Estimated value from BM-MSCs | |||||||
|---|---|---|---|---|---|---|---|---|
| Time (day) | Concentration | Time (day) | Concentration | |||||
| Scleraxis | 2.3 | 0.040 | 8.4 | 0.014 | 2.1 | 0.014 | 3.6 | 0.133 |
| Tenomodulin | 2.5 | 0.011 | 31.2 | 0.528 | 2.9 | 0.872 | 0.6 | 0.034 |
| Decorin | 4.8 | 0.891 | 1.1 | < 0.001 | 0.6 | 0.599 | 2.0 | 0.004 |
| Collagen I/III | 2.8 | 0.376 | 7.8 | < 0.001 | 2.1 | 0.009 | 2.3 | 0.018 |
| Tenacin C | 2.2 | 0.038 | 7.6 | 0.075 | 1.9 | 0.019 | 0.2 | 0.805 |
TGF-β3 transforming growth factor-beta 3, T-MSCs tonsil-derived mesenchymal stem cells, BM-MSCs bone marrow-derived mesenchymal stem cells
Fig. 2Response surface for all tenocyte lineage-related mRNAs from T-MSCs (a) and BM-MSCs (b)
ANOVA for response surface quadratic model
| MSCs | Source | Estimate | Standard error | ||
|---|---|---|---|---|---|
| T-MSCs | Intercept | 0.064 | 0.337 | 0.04 | 0.849 |
| 1.143 | 0.352 | 10.50 | 0.0013 | ||
| 0.623 | 0.151 | 16.97 | <.0001 | ||
| −0.288 | 0.058 | 11.29 | 0.0009 | ||
| −0.163 | 0.044 | 13.91 | 0.0002 | ||
| 0.105 | 0.039 | 7.08 | 0.0083 | ||
| BM-MSCs | Intercept | −1.874 | 1.142 | 2.69 | 0.1029 |
| 3.534 | 1.195 | 8.76 | 0.0035 | ||
| 0.442 | 0.513 | 0.74 | 0.3897 | ||
| −0.895 | 0.290 | 9.48 | 0.0024 | ||
| −0.064 | 0.148 | 0.18 | 0.6671 | ||
| 0.117 | 0.134 | 0.76 | 0.3855 |
MSCs mesenchymal stem cells, T-MSCs tonsil-derived mesenchymal stem cells, BM-MSCs bone marrow-derived mesenchymal stem cells, X1, day; X2, concentration of TGF-β3